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Major depressive disorder (MDD) is an independent risk
factor for the development of type 2 diabetes (T2DM)
and cardiovascular disorders (CVD). Vice versa, patients
suffering from T2DM or CVD bear an elevated risk of
developing MDD. Recent epidemiologic studies suggest
that MDD promotes the development of the metabolic
syndrome (MetS), a well known risk factor for the devel-
opment of T2DM and CVD. Furthermore, patients at
risk for type 2 diabetes have a higher incidence of the
MetS after a lifetime episode of MDD. These results
point to an important role of MDD in the development
of T2DM and CVD, and a bidirectional modulation
between MDD and T2DM/CVD. Several risk factors for
the above mentioned associations have been described.
Among these, a dysregulation of endocrine and immune
systems, sedentary lifestyle and adverse health related
behaviors have been found. Recently, a dysregulation of
the central energy metabolism has been proposed as
superordinated hypothesis to explain metabolic abnorm-
alities in the context of depression. These findings
expand our understanding of MDD as a complex, multi-
etiological and multi-system disorder. As suggested by
the joint recommendations of the EPA, EASD and ESC
on diabetes and cardiovascular risk in patients
with severe mental disorders, increased awareness of
metabolic disorders is necessary in patients with depres-
sive disorders.
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